Inactive Instrument

Pymepharco Joint Stock Company

Equities

PME

VN000000PME9

Pymepharco Joint Stock Company Announces Earnings Results for the Year 2019; Provides Earnings Guidance for 2020

May 13, 2020 at 03:50 am EDT

Pymepharco Joint Stock Company announced earnings results for the year 2019. For the period, the company reported net revenue was VND 1,846.9 billion. Profit after tax was VND 320.9 billion.

The company also provided earnings guidance for 2020. For the period, the company expects net revenue of VND 2,032 billion and Profit after tax of VND 434.5 billion.

Latest news about Pymepharco Joint Stock Company

Pymepharco Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-10-20	CI
Pymepharco Joint Stock Company Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-07-20	CI
Pymepharco Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-19	CI
Pymepharco Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-01-20	CI
Pymepharco Joint Stock Company Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-10-20	CI
Pymepharco Joint Stock Company Announces Executive Changes	20-05-13	CI
Pymepharco Joint Stock Company Announces Earnings Results for the Year 2019; Provides Earnings Guidance for 2020	20-05-13	CI
Pymepharco Joint Stock Company Announces Cash Dividend for 2019, Payable on June 02, 2020	20-05-08	CI
Pymepharco Joint Stock Company Announces Resignation of Mark Burgess Keatley as Member of BOD	20-03-11	CI
Pymepharco Joint Stock Company to Set Up a New Branch	20-02-05	CI
Pymepharco Joint Stock Company to Pay First Cash Dividend, Payable on March 2020	19-12-03	CI
Pymepharco Joint Stock Company Announces Resignation of Ludwig Otto Friedrich Klöter from Deputy CEO from April 22, 2019	19-04-16	CI
STADA Arzneimittel Aktiengesellschaft (DB:SAZ) acquired an unknown minority stake in Pymepharco Joint Stock Company.	18-12-05	CI
Pymepharco Joint Stock Company Announces Second Cash Dividend for 2017, Payable on May 31, 2018	18-05-11	CI
Pymepharco Joint Stock Company Announces Audited Earnings Results for the Year 2017; Provides Earnings Guidance for the Year 2018	18-05-10	CI
Pymepharco Joint Stock Company Announces First Phase of Cash Dividend of 2017	18-03-15	CI

Chart Pymepharco Joint Stock Company

Duration

Period

More charts

Company Profile

Pymepharco Joint Stock Company is a Vietnam-based company primarily engaged in the Pharmaceutical sector. The Company manufactures and distributes pharmaceuticals, medicinal products and materials. Its product line includes antibiotics, analgesics, antipyretics, anti-inflammatory, anti-rheumatic, anti-bacterial combinations, vitamins and minerals. The Company produces medicines in various forms, comprising tablet, soft capsule, hard capsule, granule and liquid.

Sector

More about the company